Catégories
Documents disponibles dans cette catégorie (18)
Ajouter le résultat dans votre panier Faire une suggestion Affiner la recherche
Bulletin : texte imprimé
Breastfeeding Medicine, Vol. 13 n°4 - Mai 2018
2018Editorial - Breastfeeding and the United States Opioid Epidemic ABM Protocol - ABM Clinical Protocol #12: Transitioning the Breastfeeding Preterm Infant from the Neonatal Intensive Care Unit to Home, Revised 2018 LactMed® Update - Treat[...]Bulletin : texte imprimé
Journal of Human Lactation, Vol. 34, n°4 - Novembre 2018
2018Article : texte imprimé
Jennifer Hicks, Auteur ; Elizabeth Morse, Auteur ; David K. Wyant, Auteur |Introduction: This study utilized a cross-sectional qualitative and quantitative interview-based survey to capture the infant feeding practices and barriers to exclusive breastfeeding for women in methadone maintenance therapy. Participants were[...]Article : texte imprimé
Lillian C. Tsai, Auteur ; Therese Jung Doan, Auteur |Although there is an abundance of interventional studies to increase breastfeeding rates, little is known about how to support and promote breastfeeding among mothers on opioid maintenance treatment (OMT). The studies on maternal OMT mainly focu[...]Article : texte imprimé
Nicole Yonke, Auteur ; Elizabeth Yakes Jimenez, Auteur ; Lawrence Leeman, Auteur ; Yuridia Leyva, Auteur ; Alyssa Ortega, Auteur ; Ludmila Bakhireva, Auteur |Background: Women with opioid use disorder (OUD) are encouraged to breastfeed, but have lower breastfeeding rates than the general population. Objective: We examined self-reported barriers and motivators for breastfeeding in women with OUD an[...]Article : texte imprimé
The accelerating reach of opioid use disorder in North America includes increasing prevalence among pregnant people. In Canada, the rate of Neonatal Abstinence Syndrome (NAS) rose 27% between 20122013 and 20162017, and it is estimated that 0.5[...]Article : texte imprimé
Davida M. Schiff, Auteur ; Elisha M. Wachman, Auteur ; Barbara Philipp, Auteur |Objectives: Among opioid-exposed newborns, breastfeeding is associated with less severe withdrawal signs, yet breastfeeding rates remain low. We determined the extent to which hospital, maternal, and infant characteristics are associated with br[...]Article : texte imprimé
Gillian A. Beauchamp, Auteur ; Robert G. Hendrickson, Auteur ; Daniel A. Spyker, Auteur |Introduction: We described calls to U.S. poison centers (PCs) related to potential exposure to substances through breast milk. Materials and Methods: We analyzed National Poison Data System calls between 2001 and 2017 with Exposure through b[...]Article : texte imprimé
Kelly S. McGlothen, Auteur ; Lisa M. Cleveland, Auteur ; Sara L. Gill, Auteur |Background: Several professional health organizations have made statements endorsing the safety of breastfeeding for women taking medication-assisted treatment for an opioid use disorder. Yet, breastfeeding initiation rates for this population [...]Article : texte imprimé
Ahmadai Hila, Auteur ; Andrew Crowe, Auteur ; Lisa BG Tee, Auteur |Despite the known risks associated with opioid use during breastfeeding, their place in therapy is established as part of a multimodal approach to treatment of pain in the early postpartum period. Opioids may be prescribed for post-caesarean ana[...]Article : texte imprimé
Lauren M. Jansson, Auteur ; Nancy Spencer, Auteur ; Krystle McConnell, Auteur |Background: In addition to the well-known benefits of human milk and breastfeeding for the mother and infant, breastfeeding may mitigate neonatal abstinence syndrome severity in prenatally opioid-exposed infants. However, lack of conclusive dat[...]Article : texte imprimé
It is feasible for migraineurs to breastfeed. If nondrug alternatives are ineffective, several prophylactic drugs such as certain anticonvulsants, beta-blockers, and onabotulinumtoxinA are safe for the breastfed infant. Although the new injectab[...]Article : texte imprimé
Vanessa L. Short, Auteur ; Katherine Cambareri, Auteur ; Meghan Gannon, Auteur |Background: Although current evidence suggests that there are unique benefits of breastfeeding for mothers receiving comprehensive treatment, including counseling and pharmacotherapy, for opioid use disorder (OUD) and their infants, breastfeedin[...]Article : texte imprimé
Elisha M. Wachman, Auteur ; Kelley Saia, Auteur ; Robin Humphreys, Auteur |Breastfeeding is recommended for women with opioid use disorder who are treated with methadone or buprenorphine. Infants with neonatal abstinence syndrome (NAS) secondary to in-utero opioid exposure have unique challenges related to breastfeedin[...]